Published 13 days ago • loading... • Updated 13 days ago
Rinkevics Calls for Urgent Additional Funding for Cancer and Diabetes Patients
Summary by The Baltic Times
2 Articles
2 Articles
Genomic Testing for Cancer Patients Still Rare Despite Medicare Coverage
Only a small percentage of cancer patients covered by Medicare get genomic testing to help guide their treatment, despite a 2018 increase in coverage allowing next generation sequencing testing for this purpose around the U.S. As reported in JAMA Network Open, the adoption of genomic testing in Medicare beneficiaries with cancer has increased from an average of 6.0% in 2016 to 16.7% in 2023. While this is a significant increase, the overall leve…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center2Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium





